RT Journal Article
SR Electronic
T1 Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated With Borrmann Classification
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 5507
OP 5515
DO 10.21873/anticanres.15364
VO 41
IS 11
A1 YE MA
A1 XIANXIAN LIANG
A1 LI LIU
A1 DAZHI GAO
A1 TAO YANG
A1 ROBERT M. HOFFMAN
A1 JIAN XU
YR 2021
UL http://ar.iiarjournals.org/content/41/11/5507.abstract
AB Background/Aim: The aim of the present study was to correlate the survival response to regional arterial-perfusion chemotherapy (RAPC) with Borrmann classification in patients with gastric cancer. Patients and Methods: The survival response of 270 patients with advanced gastric cancer treated with RAPC was analyzed and Borrmann classification of the tumors was retrospectively correlated to survival. Results: The median survival time of RAPC-treated patients with Borrmann type I/II was 53 months compared with 19 and 12 months for those with Borrmann type III and IV, respectively (p<0.001). Conclusion: Borrmann classification is a potential indicator to predict prognosis of patients with advanced gastric cancer treated with RAPC.